Lorsaid SD 4 Tablet contains Lornoxicam 4 mg, a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, indicated for the management of acute and chronic pain associated with inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and postoperative pain. Lornoxicam exerts its therapeutic effect by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins, which are mediators of inflammation, pain, and fever. This results in effective analgesic, anti-inflammatory, and antipyretic properties. Lorsaid SD 4 is typically administered orally, with dosing tailored to the severity of symptoms and patient response, ensuring the lowest effective dose is used for the shortest duration necessary to minimize potential adverse effects. Common side effects may include gastrointestinal disturbances such as dyspepsia, nausea, and abdominal pain; caution is advised in patients with a history of peptic ulcers or gastrointestinal bleeding. It should be used with care in individuals with renal or hepatic impairment, cardiovascular disease, or hypersensitivity to NSAIDs. Concomitant use with other NSAIDs, anticoagulants, or corticosteroids requires medical supervision to avoid increased risk of adverse events. Lorsaid SD 4 Tablet should be used under medical guidance to ensure safe and effective pain management.